Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Alpha Cognition Inc (ACOGF)

Alpha Cognition Inc (ACOGF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 12,602
  • Shares Outstanding, K 44,894
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,550 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.03
Trade ACOGF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.16
  • Most Recent Earnings -0.04 on 11/28/22
  • Next Earnings Date 11/25/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2121 +32.34%
on 10/31/22
0.4193 -33.06%
on 11/07/22
+0.0807 (+40.35%)
since 10/28/22
3-Month
0.1973 +42.27%
on 10/24/22
0.6082 -53.85%
on 09/02/22
-0.2252 (-44.51%)
since 08/26/22
52-Week
0.1973 +42.27%
on 10/24/22
1.0800 -74.01%
on 05/27/22
-0.5693 (-66.98%)
since 11/26/21

Most Recent Stories

More News
Alpha Cognition Announces Third Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.320 (-8.57%)
ACOGF : 0.2807 (+10.08%)
Alpha Cognition Announces Second Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.320 (-8.57%)
ACOGF : 0.2807 (+10.08%)
Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative...

ACOG.VN : 0.320 (-8.57%)
ACOGF : 0.2807 (+10.08%)
Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative...

ACOG.VN : 0.320 (-8.57%)
ACOGF : 0.2807 (+10.08%)
Alpha Cognition Announces Successful Defense of European Patent Covering ALPHA-0602

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.320 (-8.57%)
ACOGF : 0.2807 (+10.08%)
Alpha Cognition Announces Positive Data from Pre-Clinical Studies and Discovery of GEM Combinations with Potential for Neurodegenerative Disease Treatment

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders,...

ACOG.VN : 0.320 (-8.57%)
ACOGF : 0.2807 (+10.08%)
Alpha Cognition Announces Grant of Stock Options

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.320 (-8.57%)
ACOGF : 0.2807 (+10.08%)
Alpha Cognition Announces First Quarter 2022 Results and Company Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.320 (-8.57%)
ACOGF : 0.2807 (+10.08%)
Alpha Cognition Announces Fourth Quarter and Full Year 2021 Results and Company Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.320 (-8.57%)
ACOGF : 0.2807 (+10.08%)
Alpha Cognition Announces Change of CFO, Grant of Stock Options and Addition to the Board of Directors

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.320 (-8.57%)
ACOGF : 0.2807 (+10.08%)
PTGX : 7.63 (-2.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.2807
2nd Resistance Point 0.2807
1st Resistance Point 0.2807
Last Price 0.2807
1st Support Level 0.2807
2nd Support Level 0.2807
3rd Support Level 0.2807

See More

52-Week High 1.0800
Fibonacci 61.8% 0.7428
Fibonacci 50% 0.6387
Fibonacci 38.2% 0.5345
Last Price 0.2807
52-Week Low 0.1973

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar